unleashing the potential of perioperative immunotherapy in resectable nsclc
Published 11 months ago • 917 plays • Length 39:06Download video MP4
Download video MP3
Similar videos
-
43:46
realizing the promise of perioperative immunotherapy in resectable nsclc
-
21:36
are we closer to a cure with perioperative immunotherapy in resectable nsclc?
-
48:44
neoadjuvant, adjuvant, or both: individualized perioperative immunotherapy in resectable nsclc
-
49:11
how to integrate perioperative immunotherapy into multimodal treatment plans in resectable nsclc
-
53:19
improving survival and cure rates in resectable nsclc with perioperative immunotherapy
-
43:35
maximizing the impact of egfr-targeted therapy in resectable nsclc
-
59:37
marking new milestones with immunotherapy in locally advanced and early lung cancer
-
58:19
the implications of recent datasets for the current and future management of nsclc egfr mutations
-
41:23
multimodal management of early-stage nsclc: egfr-targeted therapy in perioperative settings
-
5:15
integrating perioperative immunotherapy strategies in nsclc
-
59:24
marking new milestones with immunotherapy in locally advanced and early lung cancer
-
1:11:21
maximizing the potential of immunotherapy in unresectable stage iii nsclc
-
1:08:00
has immunotherapy brought us to an inflection point in the management of stage i-iii nsclc?
-
1:03:31
elevating care in resectable stage i-iii nsclc
-
1:05:29
can the addition of immunotherapy to multimodal management of stage i-iii nsclc improve outcomes?
-
1:06:23
immunotherapy in lung cancer: rationale, evidence, and implications for the multidisciplinary team
-
5:30
perioperative immunotherapy for resectable nsclc: evaluating approved and emerging approaches
-
0:34
the future of chemo-immunotherapy in resectable non-small cell lung cancer
-
0:58
adherence & outcomes of neoadjuvant immunotherapy in resectable nsclc